Targeting OGG1 arrests cancer cell proliferation by inducing replication stress


Por: Visnes, T, Benitez-Buelga, C, Cazares-Korner, A, Sanjiv, K, Hanna, BMF, Mortusewicz, O, Rajagopal, V, Albers, JJ, Hagey, DW, Bekkhus, T, Eshtad, S, Baquero, JM, Masuyer, G, Wallner, O, Muller, S, Pham, T, Gokturk, C, Rasti, A, Suman, S, Torres-Ruiz, R, Sarno, A, Wiita, E, Homan, EJ, Karsten, S, Marimuthu, K, Michel, M, Koolmeister, T, Scobie, M, Loseva, O, Almlof, I, Unterlass, JE, Pettke, A, Bostrom, J, Pandey, M, Gad, H, Herr, P, Jemth, AS, El Andaloussi, S, Kalderen, C, Rodriguez-Perales, S, Benitez, J, Krokan, HE, Altun, M, Stenmark, P, Berglund, UW and Helleday, T

Publicada: 2 dic 2020
Resumen:
Altered oncogene expression in cancer cells causes loss of redox homeostasis resulting in oxidative DNA damage, e.g. 8-oxoguanine (8-oxoG), repaired by base excision repair (BER). PARP1 coordinates BER and relies on the upstream 8-oxoguanine-DNA glycosylase (OGG1) to recognise and excise 8-oxoG. Here we hypothesize that OGG1 may represent an attractive target to exploit reactive oxygen species (ROS) elevation in cancer. Although OGG1 depletion is well tolerated in non-transformed cells, we report here that OGG1 depletion obstructs A3 T-cell lymphoblastic acute leukemia growth in vitro and in vivo, validating OGG1 as a potential anti-cancer target. In line with this hypothesis, we show that OGG1 inhibitors (OGG1i) target a wide range of cancer cells, with a favourable therapeutic index compared to non-transformed cells. Mechanistically, OGG1i and shRNA depletion cause S-phase DNA damage, replication stress and proliferation arrest or cell death, representing a novel mechanistic approach to target cancer. This study adds OGG1 to the list of BER factors, e.g. PARP1, as potential targets for cancer treatment.

Filiaciones:
Visnes, T:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

 SINTEF Ind, Dept Biotechnol & Nanomed, N-7465 Trondheim, Norway

Benitez-Buelga, C:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Cazares-Korner, A:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Sanjiv, K:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Hanna, BMF:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Mortusewicz, O:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Rajagopal, V:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Albers, JJ:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Hagey, DW:
 Karolinska Inst, Dept Lab Med, Stockholm, Sweden

Bekkhus, T:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Eshtad, S:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Baquero, JM:
 Spanish Natl Canc Res Ctr CNIO, Human Genet Grp, Madrid, Spain

Masuyer, G:
 Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden

 Univ Bath, Ctr Therapeut Innovat, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England

Wallner, O:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Muller, S:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Pham, T:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Gokturk, C:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Rasti, A:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Suman, S:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

:
 Spanish Natl Canc Res Ctr CNIO, Mol Cytogenet Grp, Human Canc Genet Program, Madrid 28029, Spain

 Univ Barcelona, Sch Med, Josep Carreras Leukemia Res Inst, Barcelona 08036, Spain

 Univ Barcelona, Sch Med, Dept Biomed, Barcelona 08036, Spain

Sarno, A:
 Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway

 Liaison Comm Educ Res & Innovat Cent Norway, Trondheim, Norway

 SINTEF Ocean, Dept Environm & New Resources, N-7010 Trondheim, Norway

Wiita, E:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Homan, EJ:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Karsten, S:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Marimuthu, K:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Michel, M:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Koolmeister, T:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Scobie, M:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Loseva, O:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Almlof, I:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Unterlass, JE:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Pettke, A:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Bostrom, J:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

 Karolinska Inst, Sci Life Lab, Div Clin Physiol, Dept Lab Med, Stockholm, Sweden

Pandey, M:
 Univ Sheffield, Dept Oncol & Metab, Weston Park Canc Ctr, Sheffield S10 2RX, S Yorkshire, England

Gad, H:
 Univ Sheffield, Dept Oncol & Metab, Weston Park Canc Ctr, Sheffield S10 2RX, S Yorkshire, England

Herr, P:
 Univ Sheffield, Dept Oncol & Metab, Weston Park Canc Ctr, Sheffield S10 2RX, S Yorkshire, England

Jemth, AS:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

El Andaloussi, S:
 Karolinska Inst, Dept Lab Med, Stockholm, Sweden

Kalderen, C:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Rodriguez-Perales, S:
 Spanish Natl Canc Res Ctr CNIO, Mol Cytogenet Grp, Human Canc Genet Program, Madrid 28029, Spain

Benitez, J:
 Spanish Natl Canc Res Ctr CNIO, Human Genet Grp, Madrid, Spain

 Spanish Network Rare Dis CIBERER, Madrid, Spain

Krokan, HE:
 Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway

 Liaison Comm Educ Res & Innovat Cent Norway, Trondheim, Norway

Altun, M:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

 Karolinska Inst, Sci Life Lab, Div Clin Physiol, Dept Lab Med, Stockholm, Sweden

Stenmark, P:
 Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden

 Lund Univ, Dept Expt Med Sci, SE-22100 Lund, Sweden

Berglund, UW:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

Helleday, T:
 Karolinska Inst, Dept Oncol & Pathol, Sci Life Lab, S-17176 Stockholm, Sweden

 Univ Sheffield, Dept Oncol & Metab, Weston Park Canc Ctr, Sheffield S10 2RX, S Yorkshire, England
ISSN: 13624962





Nucleic Acids Research
Editorial
Oxford University Press, GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 48 Número: 21
Páginas: 12234-12251
WOS Id: 000606018700035
ID de PubMed: 33211885
imagen Green Published, Green Accepted, gold

MÉTRICAS